MAPS Act
- Last Action
- 7/18/2023
Actions
- 2023-07-18Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2023-07-18Introduced in Senate
CRS Summary
As of 2023-07-18 (00)
Mapping America's Pharmaceutical Supply Act or the MAPS Act
This bill requires the Department of Health and Human Services (HHS) to support efforts to map the U.S. pharmaceutical supply chain and identify associated vulnerabilities.
As part of these efforts, HHS must support the development of a database of certain essential medicines and the identification of information about their supply chain, including the location of manufacturing facilities. Qualifying essential medicines are those that are likely to be needed in the event of a public health emergency or chemical, biological, radiological, or nuclear threat or for which a shortage would pose a significant threat to the U.S. health care system or at-risk populations.
Cosponsors (2)
- James Lankford (R-OK)
- Mike Braun (R-IN)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.